Mass spectrometry (“MS”) is becoming a transformative analytical technique that has revolutionized how materials are tested and processed in various industries, such as petrochemical. The supreme accuracy of MS in analyzing the molecular structure, purity, and potency of a substance has made it an indispensable part of several key sectors. In manufacturing settings, MS is a game-changer, as it is able to enhance the production processes with higher purity and yields. A key benefit is the ability to make these determinations directly in the production process making near-real-time adjustments, versus the delays traditionally incurred by sending the samples to the lab.
The global mass spectrometry market was valued at $5.4 billion in 2023 and is expected to grow to $7.8 billion by 2028, expanding at a CAGR of 7.5% (https://ibn.fm/UvTfe). The technology’s capability to provide rapid, accurate, and detailed analysis makes it a growing preference for industries looking to enhance productivity and ensure product quality.
Astrotech (NASDAQ: ASTC), an instrumentation company that designs, manufactures, and commercializes mass spectrometry solutions, is expanding access to this technology through Pro-Control and its other vertically focused subsidiaries.
Pro-Control, a true innovator, harnesses the power of advanced mass spectrometry in its Pro-Control-1000(TM) rugged factory-floor instrument that allows production managers access to real-time testing results providing actionable information where previously it would have taken hours or days. This immediate, on-site, access to the highly accurate MS data provided by the Pro-Control-1000(TM) increases potency, purity and ending weight yields.
Role in Petrochemical Processing
Mass spectrometry is an invaluable analytical technique in the petrochemical industry, allowing for the identification and quantification of individual chemical components present in complex petroleum samples. This data is crucial for optimizing production processes, monitoring emissions, and ensuring the quality of finished products.
Application in Pharmaceutical Manufacturing
In pharmaceuticals, the precision of mass spectrometry is critical. It helps confirm drug molecules’ molecular structure and purity, which is essential for ensuring safety and efficacy. MS also plays a crucial role in identifying impurities or contaminants that might compromise the drug’s quality. Furthermore, it quantifies the levels of drugs in formulations, which is vital for accurate dosing. Another significant application is in characterizing protein-based biopharmaceuticals, such as antibodies, where MS provides essential information on molecular weight and structure.
Utility in the Food and Beverage Industry
The food and beverage sector also greatly benefits from mass spectrometry. MS techniques are used to test for pesticide residues, allergens, and other contaminants in food products. This helps ensure compliance with safety regulations and ensures consumer trust. Additionally, mass spectrometry assists in verifying the contents of nutritional labels—such as vitamins and proteins—enhancing label accuracy and transparency. It also detects food adulteration and identifies sources of spoilage or contamination, crucial for maintaining food quality.
Impact on Polymer and Materials Manufacturing
Mass spectrometry provides detailed insights into polymers’ molecular weights and compositions, which are vital for developing new materials with desired properties and performance. MS analyses additives and fillers in plastics and composites, ensuring products meet stringent quality specifications. It is also used to characterize surface coatings and thin films, critical for applications in industries like automotive and aerospace.
Role in Environmental Testing
Environmental testing is another critical application of mass spectrometry, where it identifies pollutants and toxins in air, water, and soil samples. This capability is essential for monitoring environmental health and compliance with regulations. Additionally, mass spectrometry measures isotopic ratios, aiding in geochemical and environmental tracing, which helps in understanding environmental changes and pollutant sources.
For more information, visit the company’s website at www.AstrotechCorp.com.
NOTE TO INVESTORS: The latest news and updates relating to ASTC are available in the company’s newsroom at https://ibn.fm/ASTC
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
Researchers at the University of Kentucky have identified a key genetic biomarker that treatment teams…
Computer scientists have designed an AI-based speech screening tool that could help people ascertain whether…
Izotropic is the only commercial entity with exclusive global rights to the Breast CT technology…
For years, oncologists have been baffled by why checkpoint inhibitors work for some cancer patients…
Clene is progressing toward a potential FDA accelerated approval for its ALS (Amyotrophic Lateral Sclerosis)…
According to a new survey, approximately 60% of workers in the U.S. healthcare sector are…